Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

Concerns over the rise of liver problems linked to supplement consumption are growing, with healthcare professionals urging ...

In a remarkable medical feat, a Mumbai Central-based hospital has successfully treated a rare and critical case of aluminium ...

With the prompt intervention of a multidisciplinary medical team at Wockhardt Hospital Mumbai Central, Neev was stabilised ...

A Lifesaving Innovation in the Fight Against Acute Liver Failure A revolutionary medical breakthrough is offering new hope in ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult ...

Grapefruit can also interfere with drugs used for blood pressure, heart defects, and depression or anxiety. Maria said some ...

Among the first municipalities in Illinois to prohibit stores from selling THC products, Elk Grove Village has now added ...

A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...

The addition of nab-paclitaxel to gemcitabine and cisplatin did not improve survival in advanced biliary tract cancer.